NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed) | PAR 25 251

Frequently Asked Questions (FAQs): NIAID Career Transition Award (K22, Independent Clinical Trial Not Allowed) - PAR-25-251

1) What is the NIAID Career Transition Award (K22) program?

The NIAID Career Transition Award (K22, Independent Clinical Trial Not Allowed) is an NIH grant opportunity designed to help postdoctoral fellows transition into independent academic research careers. It supports the move from mentored postdoctoral training into an assistant professor position (or an equivalent independent role) while launching an independent biomedical research program.

2) What is the main purpose of this K22 opportunity?

The core aim is to provide a structured runway for early-career investigators to secure a faculty appointment, establish a distinct research direction, and build a foundation for longer-term research funding and career stability as an independent investigator.

3) Who is the issuing agency for this grant opportunity?

This opportunity is issued by the National Institutes of Health (NIH), specifically associated with the National Institute of Allergy and Infectious Diseases (NIAID).

4) What is the Funding Opportunity Number (FOA) for this program?

The Funding Opportunity Number is PAR-25-251.

5) How is this opportunity categorized in terms of grant type and funding area?

It is categorized as a discretionary grant, and it falls under the Health funding activity area.

6) What is the CFDA number for this opportunity?

The associated CFDA number is 93.855, which corresponds to NIAID-related assistance programs.

7) What does "Independent Clinical Trial Not Allowed" mean for applicants?

It means applicants should not propose a project in which the awardee would be responsible for conducting an independent clinical trial. The announcement is not intended to support a K22 project that functions as an independently led clinical trial.

8) Does "Independent Clinical Trial Not Allowed" mean no human subjects research is allowed?

Not necessarily. The announcement notes that some human-subjects research may be permissible depending on NIH definitions and the specific details of the application, but the project should not be an independently led clinical trial under NIH definitions.

9) What types of organizations are eligible to apply?

Eligibility is broad across many U.S.-based organizations and government entities. Eligible applicants include state, county, city or township governments, special district governments, and independent school districts. Public and state-controlled institutions of higher education and private institutions of higher education are also eligible.

10) Are tribal governments and tribal organizations eligible?

Yes. Federally recognized Native American tribal governments are eligible, and the announcement also supports participation by Native American tribal organizations that are not federally recognized. It also highlights Indian/Native American Tribal Governments other than federally recognized ones as eligible.

11) Are nonprofit organizations eligible to apply?

Yes. Nonprofit organizations with 501(c)(3) status and nonprofit organizations without 501(c)(3) status are listed as eligible applicant types (in the specified categories noted in the announcement).

12) Are for-profit organizations eligible to apply?

Yes. For-profit organizations (other than small businesses) are listed as eligible, and small businesses are also listed among eligible applicant types.

13) Are public housing authorities eligible?

Yes. Public housing authorities and Indian housing authorities are listed among eligible applicant types.

14) Are institutions like HBCUs, HSIs, and TCCUs specifically mentioned as eligible?

Yes. The announcement explicitly highlights several institutional types as "other eligible applicants," including Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), and multiple other serving-institution categories.

15) Which other serving-institution categories are explicitly highlighted?

The highlighted list includes Alaska Native and Native Hawaiian Serving Institutions; Asian American, Native American, and Pacific Islander Serving Institutions (AANAPISIs); and other explicitly named institution types in the announcement.

16) Are faith-based or community-based organizations eligible to apply?

Yes. Faith-based or community-based organizations are included in the announcement as eligible to apply.

17) Are federal government agencies eligible to apply?

Yes. Eligible federal government agencies are noted as eligible applicants in the highlighted eligibility discussion.

18) Are U.S. territories or possessions eligible to apply?

Yes. The announcement notes that U.S. territories or possessions can apply.

19) Are foreign (non-U.S.) organizations eligible to apply?

No. Non-domestic (non-U.S.) entities, meaning foreign organizations, are not eligible to apply.

20) Can a U.S. organization apply if the project will be conducted through a foreign component?

No. Non-domestic components of U.S. organizations are not eligible. The applicant organization and the work supported under this opportunity are expected to be based within eligible U.S. organizational structures rather than being routed through or primarily carried out by foreign institutional components.

21) What is the maximum award amount for this opportunity?

The award ceiling listed for this opportunity is $150,000, indicating the maximum level of funding allowed as provided in the source data.

22) When was this funding opportunity created?

The opportunity was created on 2024-12-03.

23) What is the closing date for this opportunity?

The original closing date is 2028-01-07, indicating the program announcement remains open for submissions across multiple cycles, subject to NIH receipt dates and any updates to the announcement.

24) Does the long open window mean applications can be submitted at any time?

The announcement indicates a long open period through the listed closing date, but submissions are still subject to NIH receipt dates and any updates to the announcement.

25) What career stage is this opportunity intended to support?

This K22 is intended to support postdoctoral fellows transitioning from mentored postdoctoral training into an assistant professor role (or equivalent independent position) as they establish themselves as independent biomedical researchers.

26) What kind of career outcome is the K22 meant to facilitate?

The program is meant to help investigators secure a faculty appointment, start an independent research direction, and build a foundation that supports future research funding and longer-term career stability.

27) What does "assistant professor or equivalent" mean in this announcement?

The announcement describes the target transition as moving into an assistant professor position or an equivalent independent role, meaning a position that provides independence consistent with establishing an independent research program.

28) Is this opportunity focused on biomedical research?

Yes. The opportunity is described as supporting investigators as they become independent biomedical researchers and establish independent biomedical research directions.

29) Does this opportunity explicitly allow an "Other" applicant type?

Yes. The eligibility list includes an "Other" category, which NIH sometimes uses to capture additional eligible organizational forms consistent with the announcement.

30) Is this grant opportunity specifically under NIAID?

The opportunity is described as the NIAID Career Transition Award and is tied to CFDA 93.855, which corresponds to NIAID-related assistance programs.